ReWalk Robotics Ltd, a manufacturer of robotic medical devices for individuals with lower limb disabilities, announces that the Centers for Medicare & Medicaid Services (CMS) has authorized the Company as a Medicare Provider.

With this certification, the Company can now bill Medicare directly for procurement of its ReWalk Personal Exoskeleton for Medicare beneficiaries and is now listed in the Medicare.gov Supplier Directory, it notes in a media release.

“As proud pioneers in this industry, gaining Provider status is an important next step for improving access to our Personal Exoskeleton.

“However, accreditation does not guarantee coverage policies, so the Company is evaluating pathways and opportunities to adjoin accreditation with provider policies to get our Personal Exoskeleton to more members of the spinal cord injury community.”

— Larry Jasinski, ReWalk CEO

This certification follows the July issuance of the CMS Healthcare Common Procedure Coding System (HCPCS) Level II Code K1007 for the ReWalk 6.0 Exoskeleton system. The July issuance established the first such code for an exoskeleton medical device, which became effective on October 1, 2020. This certification is immediately effective in the majority of US states, and the Company is working through additional administrative tasks to achieve accreditation in most of the remaining states.

As the HCPCS code goes into effect, ReWalk will pursue in-network status with private insurance companies. This will open access to individuals who do not have out-of-network Durable Medical Equipment benefits and/or those who have high out of pocket costs with out-of-network providers.

[Source(s): ReWalk Robotics Ltd, PR Newswire]

Related Content:
ReWalk Robotics Expands Rehab Product Portfolio
ReWalk Robotics and Harvard to Continue Their Research Collaboration
Paralyzed Veteran Completes NYC Marathon Wearing a ReWalk Exoskeleton